Genetic and epigenetic dysregulation of imprinted genes in the brain

Epigenomics

Volumn 2, Issue 6, 2010, Pages 743-763

  Kernohan, Kristin D ^a,b,c   Bérubé, Nathalie G ^a,b,c,d  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b CHILDREN S HEALTH RESEARCH INSTITUTE   (Canada)

^c LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

^d NONE   (Canada)

Author keywords

Turner syndrome

Indexed keywords

DNA; HISTONE; UNTRANSLATED RNA;

ALLELE; ALPHA THALASSEMIA; BRAIN FUNCTION; CHROMATIN STRUCTURE; CHROMOSOME; DNA METHYLATION; EPIGENETICS; GENE EXPRESSION; GENE MUTATION; GENOMICS; HAPPY PUPPET SYNDROME; HISTONE MODIFICATION; HUMAN; NERVE CELL; NERVE CELL DEGENERATION; NERVOUS SYSTEM; NONHUMAN; PRADER WILLI SYNDROME; PRIORITY JOURNAL; RETT SYNDROME; REVIEW; TURNER SYNDROME; X LINKED MENTAL RETARDATION;

MAMMALIA; MUS;

EID: 78650495163     PISSN: 17501911     EISSN: 1750192X     Source Type: Journal    
DOI: 10.2217/epi.10.61     Document Type: Review

References (261)

1. Fukagawa NK, Martin JM, Wurthmann A, Prue AH, Ebenstein D, ORourke B: Sex-related differences in methionine metabolism and plasma homocysteine concentrations. Am. J. Clin. Nutr. 72(1), 22-29 (2000)
2. Spahn L, Barlow DP: An ICE pattern crystallizes. Nat. Genet. 35, 11-12 (2003).
3. Bartolomei MS, Webber AL, Brunkow ME, Tilghman SM: Epigenetic mechanisms underlying the imprinting of the mouse H19 gene. Genes Dev. 7, 1663-1673 (1993).
4. Frevel MA, Hornberg JJ, Reeve AE: A potential imprint control element: identification of a conserved 42 bp sequence upstream of H19. Trends Genet. 15, 216-218 (1999).
5. Tremblay KD, Saam JR, Ingram RS, Tilghman SM, Bartolomei MS: A paternal-specific methylation imprint marks the alleles of the mouse H19 gene. Nat. Genet. 9, 407-413 (1995).
6. Tremblay KD, Duran KL, Bartolomei MS: A 5 2-kilobase-pair region of the imprinted mouse H19 gene exhibits exclusive paternal methylation throughout development. Mol. Cell. Biol. 17, 4322-4329 (1997).
7. Brandeis M, Kafri T, Ariel M et al.: The ontogeny of allele-specific methylation associated with imprinted genes in the mouse. EMBO J. 12, 3669-3677 (1993).
8. Moore T, Constancia M, Zubair M et al.: Multiple imprinted sense and antisense transcripts, differential methylation and tandem repeats in a putative imprinting control region upstream of mouse Igf2. Proc. Natl Acad. Sci. USA 94, 12509-12514 (1997).
9. Feil R, Walter J, Allen ND, Reik W: Developmental control of allelic methylation in the imprinted mouse Igf2 and H19 genes. Development 120, 2933-2943 (1994).
10. Ferguson-Smith AC, Sasaki H, Cattanach BM, Surani MA: Parental-origin-specific epigenetic modification of the mouse H19 gene. Nature 362, 751-755 (1993).
11. Thorvaldsen JL, Duran KL, Bartolomei MS: Deletion of the H19 differentially methylated domain results in loss of imprinted expression of H19 and Igf2. Genes Dev. 12, 3693-3702 (1998).
12. Tanimoto K, Shimotsuma M, Matsuzaki H et al.: Genomic imprinting recapitulated in the human b-globin locus. Proc. Natl Acad. Sci. USA 102, 10250-10255 (2005).
13. Park KY, Sellars EA, Grinberg A, Huang SP, Pfeifer K: The H19 differentially methylated region marks the parental origin of a heterologous locus without gametic DNA methylation. Mol. Cell. Biol. 24, 3588-3595 (2004).
14. Gebert C, Kunkel D, Grinberg A, Pfeifer K: H19 imprinting control region methylation requires an imprinted environment only in the male germ line. Mol. Cell. Biol. 30, 1108-1115 (2010).
15. Howell CY, Bestor TH, Ding F et al.: Genomic imprinting disrupted by a maternal effect mutation in the Dnmt1 gene. Cell 104, 829-838 (2001).
16. Li E, Beard C, Jaenisch R: Role for DNA methylation in genomic imprinting. Nature 366, 362-365 (1993).
17. Hu JF, Nguyen PH, Pham NV, Vu TH, Hoffman AR: Modulation of Igf2 genomic imprinting in mice induced by 5-azacytidine, an inhibitor of DNA methylation. Mol. Endocrinol. 11, 1891-1898 (1997).
18. Fournier C, Goto Y, Ballestar E et al.: Allele-specific histone lysine methylation marks regulatory regions at imprinted mouse genes. Embo J. 21, 6560-6570 (2002).
19. Henckel A, Nakabayashi K, Sanz LA, Feil R, Hata K, Arnaud P: Histone methylation is mechanistically linked to DNA methylation at imprinting control regions in mammals. Hum. Mol. Genet. 18, 3375-3383 (2009).
20. Umlauf D, Goto Y, Cao R et al.: Imprinting along the Kcnq1 domain on mouse chromosome 7 involves repressive histone methylation and recruitment of Polycomb group complexes. Nat. Genet. 36, 1296-1300 (2004).
21. Regha K, Sloane MA, Huang R et al.: Active and repressive chromatin are interspersed without spreading in an imprinted gene cluster in the mammalian genome. Mol. Cell 27, 353-366 (2007).
22. Verona RI, Thorvaldsen JL, Reese KJ, Bartolomei MS: The transcriptional status but not the imprinting control region determines allele-specific histone modifications at the imprinted H19 locus. Mol. Cell. Biol. 28, 71-82 (2008).
23. Delaval K, Govin J, Cerqueira F, Rousseaux S, Khochbin S, Feil R: Differential histone modifications mark mouse imprinting control regions during spermatogenesis. EMBO J. 26, 720-729 (2007).
24. Mikkelsen TS, Ku M, Jaffe DB et al.: Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature 448, 553-560 (2007).
25. Wu Q, Kumagai T, Kawahara M et al.: Regulated expression of two sets of paternally imprinted genes is necessary for mouse parthenogenetic development to term. Reproduction 131, 481-488 (2006).
26. Lewis A, Mitsuya K, Umlauf D et al.: Imprinting on distal chromosome 7 in the placenta involves repressive histone methylation independent of DNA methylation. Nat. Genet. 36, 1291-1295 (2004). (Pubitemid 39577937)
27. Engemann S, Strodicke M, Paulsen M et al.: Sequence and functional comparison in the Beckwith-Wiedemann region: implications for a novel imprinting centre and extended imprinting. Hum. Mol. Genet. 9, 2691-2706 (2000).
28. Fitzpatrick GV, Soloway PD, Higgins MJ: Regional loss of imprinting and growth deficiency in mice with a targeted deletion of KvDMR1. Nat. Genet. 32, 426-431 (2002).
29. Lee MP, DeBaun MR, Mitsuya K et al.: Loss of imprinting of a paternally expressed transcript, with antisense orientation to KVLQT1, occurs frequently in Beckwith-Wiedemann syndrome and is independent of insulin-like growth factor II imprinting. Proc. Natl Acad. Sci. USA 96, 5203-5208 (1999).
30. Smilinich NJ, Day CD, Fitzpatrick GV et al.: A maternally methylated CpG island in KvLQT1 is associated with an antisense paternal transcript and loss of imprinting in Beckwith-Wiedemann syndrome. Proc. Natl Acad. Sci. USA 96, 8064-8069 (1999).
31. Green K, Lewis A, Dawson C et al.: A developmental window of opportunity for imprinted gene silencing mediated by DNA methylation and the Kcnq1ot1 noncoding RNA. Mamm. Genome 18, 32-42 (2007).
32. Pandey RR, Mondal T, Mohammad F et al.: Kcnq1ot1 antisense noncoding RNA mediates lineage-specific transcriptional silencing through chromatin-level regulation. Mol. Cell 32, 232-246 (2008).
33. Wagschal A, Sutherland HG, Woodfine K et al.: G9a histone methyltransferase contributes to imprinting in the mouse placenta. Mol. Cell. Biol. 28, 1104-1113 (2008).
34. Tanaka M, Puchyr M, Gertsenstein M et al.: Parental origin-specific expression of Mash2 is established at the time of implantation with its imprinting mechanism highly resistant to genome-wide demethylation. Mech. Dev. 87, 129-142 (1999).
35. Caspary T, Cleary MA, Baker CC, Guan XJ, Tilghman SM: Multiple mechanisms regulate imprinting of the mouse distal chromosome 7 gene cluster. Mol. Cell. Biol. 18, 3466-3474 (1998).
36. Mercer TR, Dinger ME, Sunkin SM, Mehler MF, Mattick JS: Specific expression of long noncoding RNAs in the mouse brain. Proc. Natl Acad. Sci. USA 105, 716-721 (2008).
37. Koerner MV, Pauler FM, Huang R, Barlow DP: The function of non-coding RNAs in genomic imprinting. Development 136, 1771-1783 (2009).
38. Royo H, Cavaille J: Non-coding RNAs in imprinted gene clusters. Biol. Cell 100, 149-166 (2008).
39. Wan LB, Bartolomei MS: Regulation of imprinting in clusters: noncoding RNAs versus insulators. Adv. Genet. 61, 207-223 (2008).
40. Lyle R, Watanabe D, te Vruchte D et al.: The imprinted antisense RNA at the Igf2r locus overlaps but does not imprint Mas1. Nat. Genet. 25, 19-21 (2000).
41. Seidl CI, Stricker SH, Barlow DP: The imprinted Air ncRNA is an atypical RNAPII transcript that evades splicing and escapes nuclear export. EMBO J. 25, 3565-3575 (2006).
42. Sleutels F, Zwart R, Barlow DP: The non-coding Air RNA is required for silencing autosomal imprinted genes. Nature 415, 810-813 (2002).
43. Sleutels F, Tjon G, Ludwig T, Barlow DP: Imprinted silencing of Slc22a2 and Slc22a3 does not need transcriptional overlap between Igf2r and Air. EMBO J. 22, 3696-3704 (2003).
44. Nagano T, Mitchell JA, Sanz LA et al.: The Air noncoding RNA epigenetically silences transcription by targeting G9a to chromatin. Science 322, 1717-1720 (2008).
45. Terranova R, Yokobayashi S, Stadler MB et al.: Polycomb group proteins Ezh2 and Rnf2 direct genomic contraction and imprinted repression in early mouse embryos. Dev. Cell 15, 668-679 (2008).
46. Dekker J, Rippe K, Dekker M, Kleckner N: Capturing chromosome conformation. Science 295, 1306-1311 (2002).
47. Zhao Z, Tavoosidana G, Sjolinder M et al.: Circular chromosome conformation capture (4C) uncovers extensive networks of epigenetically regulated intra- and interchromosomal interactions. Nat. Genet. 38, 1341-1347 (2006).
48. Dostie J, Richmond TA, Arnaout RA et al.: Chromosome conformation capture carbon copy (5C): a massively parallel solution for mapping interactions between genomic elements. Genome Res. 16, 1299-1309 (2006).
49. Fullwood MJ, Ruan Y: ChIP-based methods for the identification of long-range chromatin interactions. J. Cell Biochem. 107, 30-39 (2009).
50. Simonis M, Klous P, Splinter E et al.: Nuclear organization of active and inactive chromatin domains uncovered by chromosome conformation capture-on-chip (4C). Nat. Genet. 38, 1348-1354 (2006).
51. Lieberman-Aiden E, van Berkum NL, Williams L et al.: Comprehensive mapping of long-range interactions reveals folding principles of the human genome. Science 326, 289-293 (2009).
52. Vu TH, Nguyen AH, Hoffman AR: Loss of IGF2 imprinting is associated with abrogation of long-range intrachromosomal interactions in human cancer cells. Hum. Mol. Genet. 19, 901-919.
53. Nativio R, Wendt KS, Ito Y et al.: Cohesin is required for higher-order chromatin conformation at the imprinted IGF2-H19 locus. PLoS Genet. 5, E1000739 (2009).
54. Qiu X, Vu TH, Lu Q et al.: A complex deoxyribonucleic acid looping configuration associated with the silencing of the maternal Igf2 allele. Mol. Endocrinol. 22, 1476-1488 (2008).
55. Murrell A, Heeson S, Reik W: Interaction between differentially methylated regions partitions the imprinted genes Igf2 and H19 into parent-specific chromatin loops. Nat. Genet. 36, 889-893 (2004).
56. Li T, Hu JF, Qiu X et al.: CTCF regulates allelic expression of Igf2 by orchestrating a promoter-polycomb repressive complex 2 intrachromosomal loop. Mol. Cell. Biol. 28, 6473-6482 (2008).
57. Burke LJ, Zhang R, Bartkuhn M et al.: CTCF binding and higher order chromatin structure of the H19 locus are maintained in mitotic chromatin. EMBO J. 24, 3291-3300 (2005).
58. Kurukuti S, Tiwari VK, Tavoosidana G et al.: CTCF binding at the H19 imprinting control region mediates maternally inherited higher-order chromatin conformation to restrict enhancer access to Igf2. Proc. Natl Acad. Sci. USA 103, 10684-10689 (2006).
59. Yoon YS, Jeong S, Rong Q, Park KY, Chung JH, Pfeifer K: Analysis of the H19 ICR insulator. Mol. Cell. Biol. 27, 3499-3510 (2007).
60. Horike S, Cai S, Miyano M, Cheng JF, Kohwi-Shigematsu T: Loss of silent-chromatin looping and impaired imprinting of DLX5 in Rett syndrome. Nat. Genet. 37, 31-40 (2005).
61. Braem C, Recolin B, Rancourt RC et al.: Genomic matrix attachment region and chromosome conformation capture quantitative real time PCR assays identify novel putative regulatory elements at the imprinted Dlk1/Gtl2 locus. J. Biol. Chem. 283, 18612-18620 (2008).
62. Kernohan KD, Jiang Y, Tremblay DC et al.: ATRX partners with cohesin and MeCP2 and contributes to developmental silencing of imprinted genes in the brain. Dev. Cell. 18, 191-202 (2010).
63. Han L, Lee DH, Szabo PE: CTCF is the master organizer of domain-wide allele-specific chromatin at the H19/Igf2 imprinted region. Mol. Cell. Biol. 28, 1124-1135 (2008).
64. Ishihara K, Oshimura M, Nakao M: CTCF-dependent chromatin insulator is linked to epigenetic remodeling. Mol. Cell 23, 733-742 (2006).
65. Parelho V, Hadjur S, Spivakov M et al.: Cohesins functionally associate with CTCF on mammalian chromosome arms. Cell 132, 422-433 (2008).
66. Wendt KS, Yoshida K, Itoh T et al.: Cohesin mediates transcriptional insulation by CCCTC-binding factor. Nature 451, 796-801 (2008).
67. Guacci V, Koshland D, Strunnikov A: A direct link between sister chromatid cohesion and chromosome condensation revealed through the analysis of MCD1 in S. cerevisiae. Cell 91, 47-57 (1997).
68. Losada A, Hirano M, Hirano T: Identification of Xenopus SMC protein complexes required for sister chromatid cohesion. Genes Dev. 12, 1986-1997 (1998).
69. Michaelis C, Ciosk R, Nasmyth K: Cohesins: chromosomal proteins that prevent premature separation of sister chromatids. Cell 91, 35-45 (1997).
70. Toth A, Ciosk R, Uhlmann F, Galova M, Schleiffer A, Nasmyth K: Yeast cohesin complex requires a conserved protein, Eco1p(Ctf7), to establish cohesion between sister chromatids during DNA replication. Genes Dev. 13, 320-333 (1999).
71. Anderson DE, Losada A, Erickson HP, Hirano T: Condensin and cohesin display different arm conformations with characteristic hinge angles. J. Cell. Biol. 156, 419-424 (2002).
72. Gruber S, Haering CH, Nasmyth K: Chromosomal cohesin forms a ring. Cell 112, 765-777 (2003).
73. McGrath J, Solter D: Completion of mouse embryogenesis requires both the maternal and paternal genomes. Cell 37, 179-183 (1984).
74. McGrath J, Solter D: Inability of mouse blastomere nuclei transferred to enucleated zygotes to support development in vitro. Science 226, 1317-1319 (1984).
75. Surani MA, Barton SC, Norris ML: Development of reconstituted mouse eggs suggests imprinting of the genome during gametogenesis. Nature 308, 548-550 (1984).
76. Frost JM, Moore GE: The importance of imprinting in the human placenta. PLoS Genet. 6, E1001015 (2010).
77. Maccani MA, Marsit CJ: Epigenetics in the placenta. Am. J. Reprod. Immunol. 62, 78-89 (2009).
78. Allen ND, Logan K, Lally G, Drage DJ, Norris ML, Keverne EB: Distribution of parthenogenetic cells in the mouse brain and their influence on brain development and behavior. Proc. Natl Acad. Sci. USA 92, 10782-10786 (1995).
79. Mann JR, Gadi I, Harbison ML, Abbondanzo SJ, Stewart CL: Androgenetic mouse embryonic stem cells are pluripotent and cause skeletal defects in chimeras: implications for genetic imprinting. Cell 62, 251-260 (1990).
80. Keverne EB, Fundele R, Narasimha M, Barton SC, Surani MA: Genomic imprinting and the differential roles of parental genomes in brain development. Brain Res. Dev. Brain Res. 92, 91-100 (1996).
81. Kuroiwa Y, Kaneko-Ishino T, Kagitani F et al.: Peg3 imprinted gene on proximal chromosome 7 encodes for a zinc finger protein. Nat. Genet. 12, 186-190 (1996).
82. Wu C, Orozco C, Boyer J et al.: BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources. Genome Biol. 10, R130 (2009).
83. Kobayashi S, Kohda T, Ichikawa H et al.: Paternal expression of a novel imprinted gene, Peg12/Frat3, in the mouse 7C region homologous to the Prader-Willi syndrome region. Biochem. Biophys. Res. Commun. 290, 403-408 (2002).
84. Davies W, Isles AR, Wilkinson LS: Imprinted gene expression in the brain. Neurosci. Biobehav. Rev. 29, 421-430 (2005).
85. Lefebvre L, Viville S, Barton SC, Ishino F, Keverne EB, Surani MA: Abnormal maternal behaviour and growth retardation associated with loss of the imprinted gene Mest. Nat. Genet. 20, 163-169 (1998).
86. Li L, Keverne EB, Aparicio SA, Ishino F, Barton SC, Surani MA: Regulation of maternal behavior and offspring growth by paternally expressed Peg3. Science 284, 330-333 (1999).
87. Davies W, Smith RJ, Kelsey G, Wilkinson LS: Expression patterns of the novel imprinted genes Nap1l5 and Peg13 and their non-imprinted host genes in the adult mouse brain. Gene Expr. Patterns 4, 741-747 (2004).
88. Lee S, Walker CL, Wevrick R: Prader-Willi syndrome transcripts are expressed in phenotypically significant regions of the developing mouse brain. Gene Expr. Patterns 3, 599-609 (2003).
89. Lein ES, Hawrylycz MJ, Ao N et al.: Genome-wide atlas of gene expression in the adult mouse brain. Nature 445, 168-176 (2007).
90. Bartolomei MS, Zemel S, Tilghman SM: Parental imprinting of the mouse H19 gene. Nature 351, 153-155 (1991).
91. Kim J, Lu X, Stubbs L: Zim1, a maternally expressed mouse Kruppel-type zinc-finger gene located in proximal chromosome 7. Hum. Mol. Genet. 8, 847-854 (1999).
92. Liu Q, Wang Y, Chen Y et al.: The expression analysis of Grb10 during mouse embryonic development. Yi Chuan 31, 732-740 (2009).
93. Ball ST, Williamson CM, Hayes C, Hacker T, Peters J: The spatial and temporal expression pattern of Nesp and its antisense Nespas, in mid-gestation mouse embryos. Mech. Dev. 100, 79-81 (2001).
94. Peters J, Wroe SF, Wells CA et al.: A cluster of oppositely imprinted transcripts at the Gnas locus in the distal imprinting region of mouse chromosome 2. Proc. Natl Acad. Sci. USA 96, 3830-3835 (1999).
95. McLaughlin D, Vidaki M, Renieri E, Karagogeos D: Expression pattern of the maternally imprinted gene Gtl2 in the forebrain during embryonic development and adulthood. Gene Expr. Patterns 6, 394-399 (2006).
96. DeChiara TM, Efstratiadis A, Robertson EJ: A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature 345, 78-80 (1990).
97. Hu ZQ, Zhang JY, Ji CN, Xie Y, Chen JZ, Mao YM: Grb10 interacts with Bim L and inhibits apoptosis. Mol. Biol. Rep. 37(7), 3547-3552 (2010).
98. Hoshiya H, Meguro M, Kashiwagi A, Okita C, Oshimura M: Calcr, a brain-specific imprinted mouse calcitonin receptor gene in the imprinted cluster of the proximal region of chromosome 6. J. Hum. Genet. 48, 208-211 (2003).
99. Rougeulle C, Glatt H, Lalande M: The Angelman syndrome candidate gene, UBE3A/E6-AP, is imprinted in brain. Nat. Genet. 17, 14-15 (1997).
100. Vu TH, Hoffman AR: Imprinting of the Angelman syndrome gene, UBE3A, is restricted to brain. Nat. Genet. 17, 12-13 (1997).
101. DeChiara TM, Robertson EJ, Efstratiadis A: Parental imprinting of the mouse insulin-like growth factor II gene. Cell 64, 849-859 (1991).
102. Wang Y, Joh K, Masuko S et al.: The mouse Murr1 gene is imprinted in the adult brain, presumably due to transcriptional interference by the antisense-oriented U2af1-rs1 gene. Mol. Cell. Biol. 24, 270-279 (2004).
103. Gregg C, Zhang J, Butler JE, Haig D, Dulac C: Sex-specific parent-of-origin allelic expression in the mouse brain. Science 329(5992), 682-685 (2010).
104. Gregg C, Zhang J, Weissbourd B et al.: High-resolution analysis of parent-of-origin allelic expression in the mouse brain. Science 329(5992), 643-648 (2010).
105. Zhou Y, Zhong Y, Wang Y et al.: Activation of p53 by MEG3 non-coding RNA. J. Biol. Chem. 282, 24731-24742 (2007).
106. Anderson SA, Eisenstat DD, Shi L, Rubenstein JL: Interneuron migration from basal forebrain to neocortex: dependence on Dlx genes. Science 278, 474-476 (1997).
107. Stuhmer T, Anderson SA, Ekker M, Rubenstein JL: Ectopic expression of the Dlx genes induces glutamic acid decarboxylase and Dlx expression. Development 129, 245-252 (2002).
108. Meguro M, Mitsuya K, Sui H et al.: Evidence for uniparental, paternal expression of the human GABAA receptor subunit genes, using microcell-mediated chromosome transfer. Hum. Mol. Genet. 6, 2127-2133 (1997).
109. Wagstaff J, Chaillet JR, Lalande M: The GABAA receptor b 3 subunit gene: characterization of a human cDNA from chromosome 15q11q13 and mapping to a region of conserved synteny on mouse chromosome 7. Genomics 11, 1071-1078 (1991).
110. Liljelund P, Handforth A, Homanics GE, Olsen RW: GABAA receptor b3 subunit gene-deficient heterozygous mice show parent-of-origin and gender-related differences in b3 subunit levels, EEG, and behavior. Brain Res. Dev. Brain Res. 157, 150-161 (2005).
111. Cremer T, Cremer M: Chromosome territories. Cold Spring Harb. Perspect. Biol. 2(3), a003889 (2010).
112. Zhao R, Bodnar MS, Spector DL: Nuclear neighborhoods and gene expression. Curr. Opin. Genet. Dev. 19, 172-179 (2009).
113. Leung KN, Vallero RO, DuBose AJ, Resnick JL, LaSalle JM: Imprinting regulates mammalian snoRNA-encoding chromatin decondensation and neuronal nucleolar size. Hum. Mol. Genet. 18, 4227-4238 (2009).
114. Schule B, Li HH, Fisch-Kohl C, Purmann C, Francke U: DLX5 and DLX6 expression is biallelic and not modulated by MeCP2 deficiency. Am. J. Hum. Genet. 81, 492-506 (2007).
115. Miyano M, Horike S, Cai S, Oshimura M, Kohwi-Shigematsu T: DLX5 expression is monoallelic and Dlx5 is up-regulated in the Mecp2-null frontal cortex. J. Cell. Mol. Med. 12, 1188-1191 (2008).
116. Reik W, Murrell A, Lewis A et al.: Chromosome loops, insulators, and histone methylation: new insights into regulation of imprinting in clusters. Cold Spring Harb. Symp. Quant. Biol. 69, 29-37 (2004).
117. Varrault A, Gueydan C, Delalbre A et al.: Zac1 regulates an imprinted gene network critically involved in the control of embryonic growth. Dev. Cell 11, 711-722 (2006).
118. Lui JC, Finkielstain GP, Barnes KM, Baron J: An imprinted gene network that controls mammalian somatic growth is down-regulated during postnatal growth deceleration in multiple organs. Am. J. Physiol. Regul. Integr. Comp. Physiol. 295, R189-R196 (2008).
119. Andrade AC, Lui JC, Nilsson O: Temporal and spatial expression of a growth-regulated network of imprinted genes in growth plate. Pediatr. Nephrol. 25, 617-623 (2010).
120. Ling JQ, Li T, Hu JF et al.: CTCF mediates interchromosomal colocalization between Igf2/H19 and Wsb1/Nf1. Science 312, 269-272 (2006).
121. Sandhu KS, Shi C, Sjolinder M et al.: Nonallelic transvection of multiple imprinted loci is organized by the H19 imprinting control region during germline development. Genes Dev. 23, 2598-2603 (2009).
122. Gabory A, Ripoche MA, Le Digarcher A et al.: H19 acts as a trans regulator of the imprinted gene network controlling growth in mice. Development 136, 3413-3421 (2009).
123. Holm VA, Cassidy SB, Butler MG et al.: Prader-Willi syndrome: consensus diagnostic criteria. Pediatrics 91, 398-402 (1993).
124. Gunay-Aygun M, Schwartz S, Heeger S, O'Riordan MA, Cassidy SB: The changing purpose of Prader-Willi syndrome clinical diagnostic criteria and proposed revised criteria. Pediatrics 108, E92 (2001).
125. Relkovic D, Doe CM, Humby T et al.: Behavioural and cognitive abnormalities in an imprinting centre deletion mouse model for Prader-Willi syndrome. Eur. J. Neurosci. 31, 156-164 (2010).
126. Runte M, Huttenhofer A, Gross S, Kiefmann M, Horsthemke B, Buiting K: The IC-SNURF-SNRPN transcript serves as a host for multiple small nucleolar RNA species and as an antisense RNA for UBE3A. Hum. Mol. Genet. 10, 2687-2700 (2001).
127. Cavaille J, Buiting K, Kiefmann M et al.: Identification of brain-specific and imprinted small nucleolar RNA genes exhibiting an unusual genomic organization. Proc. Natl Acad. Sci. USA 97, 14311-14316 (2000).
128. Bressler J, Tsai TF, Wu MY et al.: The SNRPN promoter is not required for genomic imprinting of the Prader-Willi/ Angelman domain in mice. Nat. Genet. 28, 232-240 (2001).
129. Yang T, Adamson TE, Resnick JL et al.: A mouse model for Prader-Willi syndrome imprinting-centre mutations. Nat. Genet. 19, 25-31 (1998).
130. Lee S, Walker CL, Karten B et al.: Essential role for the Prader-Willi syndrome protein necdin in axonal outgrowth. Hum. Mol. Genet. 14, 627-637 (2005).
131. Pagliardini S, Ren J, Wevrick R, Greer JJ: Developmental abnormalities of neuronal structure and function in prenatal mice lacking the Prader-Willi syndrome gene necdin. Am. J. Pathol. 167, 175-191 (2005).
132. Tennese AA, Gee CB, Wevrick R: Loss of the Prader-Willi syndrome protein necdin causes defective migration, axonal outgrowth, and survival of embryonic sympathetic neurons. Dev. Dyn. 237, 1935-1943 (2008).
133. Kuwako K, Hosokawa A, Nishimura I et al.: Disruption of the paternal necdin gene diminishes TrkA signaling for sensory neuron survival. J. Neurosci. 25, 7090-7099 (2005).
134. Andrieu D, Meziane H, Marly F, Angelats C, Fernandez PA, Muscatelli F: Sensory defects in Necdin deficient mice result from a loss of sensory neurons correlated within an increase of developmental programmed cell death. BMC Dev. Biol. 6, 56 (2006).
135. Ingraham CA, Schor NF: Necdin and TrkA contribute to modulation by p75NTR of resistance to oxidant stress. Exp. Cell Res. 315, 3532-3542 (2009).
136. Kurita M, Kuwajima T, Nishimura I, Yoshikawa K: Necdin downregulates CDC2 expression to attenuate neuronal apoptosis. J. Neurosci. 26, 12003-12013 (2006).
137. Kuwajima T, Nishimura I, Yoshikawa K: Necdin promotes GABAergic neuron differentiation in cooperation with Dlx homeodomain proteins. J. Neurosci. 26, 5383-5392 (2006).
138. Tseng YH, Butte AJ, Kokkotou E et al.: Prediction of preadipocyte differentiation by gene expression reveals role of insulin receptor substrates and necdin. Nat. Cell Biol. 7, 601-611 (2005).
139. Bischof JM, Stewart CL, Wevrick R: Inactivation of the mouse Magel2 gene results in growth abnormalities similar to Prader-Willi syndrome. Hum. Mol. Genet. 16, 2713-2719 (2007).
140. Skryabin BV, Gubar LV, Seeger B et al.: Deletion of the MBII-85 snoRNA gene cluster in mice results in postnatal growth retardation. PLoS Genet. 3, E235 (2007).
141. Ding F, Li HH, Zhang S et al.: SnoRNA Snord116 (Pwcr1/MBII-85) deletion causes growth deficiency and hyperphagia in mice. PLoS One 3, E1709 (2008).
142. Sahoo T, del Gaudio D, German JR et al.: Prader-Willi phenotype caused by paternal deficiency for the HBII-85 C/D box small nucleolar RNA cluster. Nat. Genet. 40, 719-721 (2008).
143. de Smith AJ, Purmann C, Walters RG et al.: A deletion of the HBII-85 class of small nucleolar RNAs (snoRNAs) is associated with hyperphagia, obesity and hypogonadism. Hum. Mol. Genet. 18, 3257-3265 (2009).
144. de los Santos T, Schweizer J, Rees CA, Francke U: Small evolutionarily conserved RNA, resembling C/D box small nucleolar RNA, is transcribed from PWCR1, a novel imprinted gene in the Prader-Willi deletion region, which is highly expressed in brain. Am. J. Hum. Genet. 67, 1067-1082 (2000).
145. Ni J, Tien AL, Fournier MJ: Small nucleolar RNAs direct site-specific synthesis of pseudouridine in ribosomal RNA. Cell 89, 565-573 (1997).
146. Dunbar DA, Baserga SJ: The U14 snoRNA is required for 2-O-methylation of the pre-18S rRNA in Xenopus oocytes. RNA 4, 195-204 (1998).
147. Kishino T, Lalande M, Wagstaff J: UBE3A/E6-AP mutations cause Angelman syndrome. Nat. Genet. 15, 70-73 (1997).
148. Matsuura T, Sutcliffe JS, Fang P et al.: De novo truncating mutations in E6-AP ubiquitin-protein ligase gene (UBE3A) in Angelman syndrome. Nat. Genet. 15, 74-77 (1997).
149. Bower BD, Jeavons PM: The happy puppet syndrome. Arch. Dis. Child 42, 298-302 (1967).
150. Lossie AC, Whitney MM, Amidon D et al.: Distinct phenotypes distinguish the molecular classes of Angelman syndrome. J. Med. Genet. 38, 834-845 (2001).
151. Williams CA, Beaudet AL, Clayton-Smith J et al.: Angelman syndrome 2005: updated consensus for diagnostic criteria. Am. J. Med. Genet. A 140, 413-418 (2006).
152. Dan B: Angelman syndrome: current understanding and research prospects. Epilepsia 50, 2331-2339 (2009).
153. Albrecht U, Sutcliffe JS, Cattanach BM et al.: Imprinted expression of the murine Angelman syndrome gene, Ube3a, in hippocampal and Purkinje neurons. Nat. Genet. 17, 75-78 (1997).
154. Dindot SV, Antalffy BA, Bhattacharjee MB, Beaudet AL: The Angelman syndrome ubiquitin ligase localizes to the synapse and nucleus, and maternal deficiency results in abnormal dendritic spine morphology. Hum. Mol. Genet. 17, 111-118 (2008).
155. Yamasaki K, Joh K, Ohta T et al.: Neurons but not glial cells show reciprocal imprinting of sense and antisense transcripts of Ube3a. Hum. Mol. Genet. 12, 837-847 (2003).
156. Gustin RM, Bichell TJ, Bubser M et al.: Tissue-specific variation of Ube3a protein expression in rodents and in a mouse model of Angelman syndrome. Neurobiol. Dis. 39(3), 283-291 (2010).
157. Landers M, Bancescu DL, Le Meur E et al.: Regulation of the large (approximately 1000 kb) imprinted murine Ube3a antisense transcript by alternative exons upstream of Snurf/Snrpn. Nucleic Acids Res. 32, 3480-3492 (2004).
158. Rougeulle C, Cardoso C, Fontes M, Colleaux L, Lalande M: An imprinted antisense RNA overlaps UBE3A and a second maternally expressed transcript. Nat. Genet. 19, 15-16 (1998).
159. Glessner JT, Wang K, Cai G et al.: Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature 459, 569-573 (2009).
160. Samaco RC, Hogart A, LaSalle JM: Epigenetic overlap in autism-spectrum neurodevelopmental disorders: MECP2 deficiency causes reduced expression of UBE3A and GABRB3. Hum. Mol. Genet. 14, 483-492 (2005).
161. Makedonski K, Abuhatzira L, Kaufman Y, Razin A, Shemer R: MeCP2 deficiency in Rett syndrome causes epigenetic aberrations at the PWS/AS imprinting center that affects UBE3A expression. Hum. Mol. Genet. 14, 1049-1058 (2005).
162. Jedele KB: The overlapping spectrum of Rett and Angelman syndromes: a clinical review. Semin. Pediatr. Neurol. 14, 108-117 (2007).
163. Jiang YH, Armstrong D, Albrecht U et al.: Mutation of the Angelman ubiquitin ligase in mice causes increased cytoplasmic p53 and deficits of contextual learning and long-term potentiation. Neuron 21, 799-811 (1998).
164. Miura K, Kishino T, Li E et al.: Neurobehavioral and electroencephalographic abnormalities in Ube3a maternal-deficient mice. Neurobiol. Dis. 9, 149-159 (2002).
165. Yashiro K, Riday TT, Condon KH et al.: Ube3a is required for experience-dependent maturation of the neocortex. Nat. Neurosci. 12, 777-783 (2009).
166. Sato M, Stryker MP: Genomic imprinting of experience-dependent cortical plasticity by the ubiquitin ligase gene Ube3a. Proc. Natl Acad. Sci. USA 107, 5611-5616 (2010).
167. Weeber EJ, Jiang YH, Elgersma Y et al.: Derangements of hippocampal calcium/ calmodulin-dependent protein kinase II in a mouse model for Angelman mental retardation syndrome. J. Neurosci. 23, 2634-2644 (2003).
168. Kumar S, Talis AL, Howley PM: Identification of HHR23A as a substrate for E6-associated protein-mediated ubiquitination. J. Biol. Chem. 274, 18785-18792 (1999).
169. Reiter LT, Seagroves TN, Bowers M, Bier E: Expression of the Rho-GEF Pbl/ECT2 is regulated by the UBE3A E3 ubiquitin ligase. Hum. Mol. Genet. 15, 2825-2835 (2006).
170. Louria-Hayon I, Alsheich-Bartok O, Levav-Cohen Y et al.: E6AP promotes the degradation of the PML tumor suppressor. Cell Death Differ. 16, 1156-1166 (2009).
171. Greer PL, Hanayama R, Bloodgood BL et al.: The Angelman syndrome protein Ube3A regulates synapse development by ubiquitinating arc. Cell 140, 704-716.
172. Good CD, Lawrence K, Thomas NS et al.: Dosage-sensitive X-linked locus influences the development of amygdala and orbitofrontal cortex, and fear recognition in humans. Brain 126, 2431-2446 (2003).
173. Elsheikh M, Dunger DB, Conway GS, Wass JA: Turners syndrome in adulthood. Endocr. Rev. 23, 120-140 (2002).
174. McCauley E, Kay T, Ito J, Treder R: The Turner syndrome: cognitive deficits, affective discrimination, and behavior problems. Child Dev. 58, 464-473 (1987).
175. McCauley E, Feuillan P, Kushner H, Ross JL: Psychosocial development in adolescents with Turner syndrome. J. Dev. Behav. Pediatr. 22, 360-365 (2001).
176. Ross JL, Roeltgen D, Feuillan P, Kushner H, Cutler GB Jr: Use of estrogen in young girls with Turner syndrome: effects on memory. Neurology 54, 164-170 (2000).
177. Skuse DH, James RS, Bishop DV et al.: Evidence from Turners syndrome of an imprinted X-linked locus affecting cognitive function. Nature 387, 705-708 (1997).
178. Bishop DV, Canning E, Elgar K, Morris E, Jacobs PA, Skuse DH: Distinctive patterns of memory function in subgroups of females with Turner syndrome: evidence for imprinted loci on the X-chromosome affecting neurodevelopment. Neuropsychologia 38, 712-721 (2000).
179. Donnelly SL, Wolpert CM, Menold MM et al.: Female with autistic disorder and monosomy X (Turner syndrome): parent-of-origin effect of the X chromosome. Am. J. Med. Genet. 96, 312-316 (2000).
180. Murphy DG, DeCarli C, Daly E et al.: X-chromosome effects on female brain: a magnetic resonance imaging study of Turners syndrome. Lancet 342, 1197-1200 (1993).
181. Reiss AL, Mazzocco MM, Greenlaw R, Freund LS, Ross JL: Neurodevelopmental effects of X monosomy: a volumetric imaging study. Ann. Neurol. 38, 731-738 (1995).
182. Kesler SR, Garrett A, Bender B, Yankowitz J, Zeng SM, Reiss AL: Amygdala and hippocampal volumes in Turner syndrome: a high-resolution MRI study of X-monosomy. Neuropsychologia 42, 1971-1978 (2004).
183. Kesler SR, Blasey CM, Brown WE et al.: Effects of X-monosomy and X-linked imprinting on superior temporal gyrus morphology in Turner syndrome. Biol. Psychiatry 54, 636-646 (2003).
184. Lynn PM, Davies W: The 39,XO mouse as a model for the neurobiology of Turner syndrome and sex-biased neuropsychiatric disorders. Behav. Brain Res. 179, 173-182 (2007).
185. Raefski AS, ONeill MJ: Identification of a cluster of X-linked imprinted genes in mice. Nat. Genet. 37, 620-624 (2005).
186. Davies W, Isles A, Smith R et al.: Xlr3b is a new imprinted candidate for X-linked parent-of-origin effects on cognitive function in mice. Nat. Genet. 37, 625-629 (2005).
187. Escalier D, Allenet B, Badrichani A, Garchon HJ: High level expression of the Xlr nuclear protein in immature thymocytes and colocalization with the matrix-associated region-binding SATB1 protein. J. Immunol. 162, 292-298 (1999).
188. Martinez-Garay I, Jablonka S, Sutajova M, Steuernagel P, Gal A, Kutsche K: A new gene family (FAM9) of low-copy repeats in Xp22.3 expressed exclusively in testis: implications for recombinations in this region. Genomics 80, 259-267 (2002).
189. Cubelos B, Sebastian-Serrano A, Beccari L et al.: Cux1 and Cux2 regulate dendritic branching, spine morphology, and synapses of the upper layer neurons of the cortex. Neuron 66, 523-535 (2010).
190. Thomas NS, Sharp AJ, Browne CE, Skuse D, Hardie C, Dennis NR: Xp deletions associated with autism in three females. Hum. Genet. 104, 43-48 (1999).
191. Milunsky J, Huang XL, Wyandt HE, Milunsky A: Schizophrenia susceptibility gene locus at Xp22.3. Clin. Genet. 55, 455-460 (1999).
192. Dobson MJ, Pearlman RE, Karaiskakis A, Spyropoulos B, Moens PB: Synaptonemal complex proteins: occurrence, epitope mapping and chromosome disjunction. J. Cell Sci. 107(Pt. 10), 2749-2760 (1994).
193. Shahbazian MD, Zoghbi HY: Molecular genetics of Rett syndrome and clinical spectrum of MECP2 mutations. Curr. Opin. Neurol. 14, 171-176 (2001).
194. Armstrong DD: Neuropathology of Rett syndrome. Ment. Retard. Dev. Disabil. Res. Rev. 8, 72-76 (2002).
195. Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY: Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat. Genet. 23, 185-188 (1999).
196. Lewis JD, Meehan RR, Henzel WJ et al.: Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA. Cell 69, 905-914 (1992).
197. Meehan RR, Lewis JD, Bird AP: Characterization of MeCP2, a vertebrate DNA binding protein with affinity for methylated DNA. Nucleic Acids Res. 20, 5085-5092 (1992).
198. Kishi N, Macklis JD: MECP2 is progressively expressed in post-migratory neurons and is involved in neuronal maturation rather than cell fate decisions. Mol. Cell Neurosci. 27, 306-321 (2004).
199. Balmer D, Goldstine J, Rao YM, LaSalle JM: Elevated methyl-CpG-binding protein 2 expression is acquired during postnatal human brain development and is correlated with alternative polyadenylation. J. Mol. Med. 81, 61-68 (2003).
200. Nan X, Ng HH, Johnson CA et al.: Transcriptional repression by the methyl- CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 393, 386-389 (1998).
201. Jordan C, Li HH, Kwan HC, Francke U: Cerebellar gene expression profiles of mouse models for Rett syndrome reveal novel MeCP2 targets. BMC Med. Genet. 8, 36 (2007).
202. Nuber UA, Kriaucionis S, Roloff TC et al.: Up-regulation of glucocorticoid-regulated genes in a mouse model of Rett syndrome. Hum. Mol. Genet. 14, 2247-2256 (2005).
203. Tudor M, Akbarian S, Chen RZ, Jaenisch R: Transcriptional profiling of a mouse model for Rett syndrome reveals subtle transcriptional changes in the brain. Proc. Natl Acad. Sci. USA 99, 15536-15541 (2002).
204. Urdinguio RG, Lopez-Serra L, Lopez-Nieva P et al.: Mecp2-null mice provide new neuronal targets for Rett syndrome. PLoS One 3, E3669 (2008).
205. Young JI, Hong EP, Castle JC et al.: Regulation of RNA splicing by the methylation-dependent transcriptional repressor methyl-CpG binding protein 2. Proc. Natl Acad. Sci. USA 102, 17551-17558 (2005).
206. Skene PJ, Illingworth RS, Webb S et al.: Neuronal MeCP2 is expressed at near histone-octamer levels and globally alters the chromatin state. Mol. Cell 37, 457-468 (2010).
207. Chen RZ, Akbarian S, Tudor M, Jaenisch R: Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat. Genet. 27, 327-331 (2001).
208. Guy J, Hendrich B, Holmes M, Martin JE, Bird A: A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat. Genet. 27, 322-326 (2001).
209. Shahbazian M, Young J, Yuva-Paylor L et al.: Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3. Neuron 35, 243-254 (2002).
210. Luikenhuis S, Giacometti E, Beard CF, Jaenisch R: Expression of MeCP2 in postmitotic neurons rescues Rett syndrome in mice. Proc. Natl Acad. Sci. USA 101, 6033-6038 (2004).
211. Giacometti E, Luikenhuis S, Beard C, Jaenisch R: Partial rescue of MeCP2 deficiency by postnatal activation of MeCP2. Proc. Natl Acad. Sci. USA 104, 1931-1936 (2007).
212. Tropea D, Giacometti E, Wilson NR et al.: Partial reversal of Rett syndrome-like symptoms in MeCP2 mutant mice. Proc. Natl Acad. Sci. USA 106, 2029-2034 (2009).
213. Guy J, Gan J, Selfridge J, Cobb S, Bird A: Reversal of neurological defects in a mouse model of Rett syndrome. Science 315, 1143-1147 (2007).
214. LaSalle JM: The odyssey of MeCP2 and parental imprinting. Epigenetics 2, 5-10 (2007).
215. Jordan C, Francke U: Ube3a expression is not altered in Mecp2 mutant mice. Hum. Mol. Genet. 15, 2210-2215 (2006).
216. Weitzel JM, Buhrmester H, Stratling WH: Chicken MAR-binding protein ARBP is homologous to rat methyl-CpG-binding protein MeCP2. Mol. Cell. Biol. 17, 5656-5666 (1997).
217. Stratling WH, Yu F: Origin and roles of nuclear matrix proteins. Specific functions of the MAR-binding protein MeCP2/ARBP. Crit. Rev. Eukaryot. Gene Expr. 9, 311-318 (1999).
218. Nomura T, Kimura M, Horii T et al.: MeCP2-dependent repression of an imprinted miR-184 released by depolarization. Hum. Mol. Genet. 17, 1192-1199 (2008).
219. Fuks F, Hurd PJ, Wolf D, Nan X, Bird AP, Kouzarides T: The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation. J. Biol. Chem. 278, 4035-4040 (2003).
220. Drewell RA, Goddard CJ, Thomas JO, Surani MA: Methylation-dependent silencing at the H19 imprinting control region by MeCP2. Nucleic Acids Res. 30, 1139-1144 (2002).
221. Nan X, Hou J, Maclean A et al.: Interaction between chromatin proteins MECP2 and ATRX is disrupted by mutations that cause inherited mental retardation. Proc. Natl Acad. Sci. USA 104, 2709-2714 (2007).
222. Gibbons RJ, McDowell TL, Raman S et al.: Mutations in ATRX, encoding a SWI/ SNF-like protein, cause diverse changes in the pattern of DNA methylation. Nat. Genet. 24, 368-371 (2000).
223. Picketts DJ, Higgs DR, Bachoo S, Blake DJ, Quarrell OW, Gibbons RJ: ATRX encodes a novel member of the SNF2 family of proteins: mutations point to a common mechanism underlying the ATR-X syndrome. Hum. Mol. Genet. 5, 1899-1907 (1996).
224. Seah C, Levy MA, Jiang Y et al.: Neuronal death resulting from targeted disruption of the Snf2 protein ATRX is mediated by p53. J. Neurosci. 28, 12570-12580 (2008).
225. Abidi FE, Cardoso C, Lossi AM et al.: Mutation in the 5 alternatively spliced region of the XNP/ATR-X gene causes Chudley-Lowry syndrome. Eur J. Hum. Genet. 13, 176-183 (2005).
226. Ritchie K, Seah C, Moulin J, Isaac C, Dick F, Berube NG: Loss of ATRX leads to chromosome cohesion and congression defects. J. Cell. Biol. 180, 315-324 (2008).
227. De La Fuente R, Viveiros MM, Wigglesworth K, Eppig JJ: ATRX, a member of the SNF2 family of helicase/ATPases, is required for chromosome alignment and meiotic spindle organization in metaphase II stage mouse oocytes. Dev. Biol. 272, 1-14 (2004).
228. McDowell TL, Gibbons RJ, Sutherland H et al.: Localization of a putative transcriptional regulator (ATRX) at pericentromeric heterochromatin and the short arms of acrocentric chromosomes. Proc. Natl Acad. Sci. USA 96, 13983-13988 (1999).
229. Berube NG, Smeenk CA, Picketts DJ: Cell cycle-dependent phosphorylation of the ATRX protein correlates with changes in nuclear matrix and chromatin association. Hum. Mol. Genet. 9, 539-547 (2000).
230. Garrick D, Sharpe JA, Arkell R et al.: Loss of Atrx affects trophoblast development and the pattern of X-inactivation in extraembryonic tissues. PLoS Genet. 2, E58 (2006).
231. Berube NG, Mangelsdorf M, Jagla M et al.: The chromatin-remodeling protein ATRX is critical for neuronal survival during corticogenesis. J. Clin. Invest. 115, 258-267 (2005).
232. Levy MA, Fernandes AD, Tremblay DC, Seah C, Berube NG: The SWI/SNF protein ATRX co-regulates pseudoautosomal genes that have translocated to autosomes in the mouse genome. BMC Genomics 9, 468 (2008).
233. Mill J, Richards S, Knight J, Curran S, Taylor E, Asherson P: Haplotype analysis of SNAP-25 suggests a role in the aetiology of ADHD. Mol. Psychiatry 9, 801-810 (2004).
234. Kustanovich V, Merriman B, McGough J, McCracken JT, Smalley SL, Nelson SF: Biased paternal transmission of SNAP-25 risk alleles in attention-deficit hyperactivity disorder. Mol. Psychiatry 8, 309-315 (2003).
235. Kent L, Green E, Hawi Z et al.: Association of the paternally transmitted copy of common Valine allele of the Val66Met polymorphism of the brain-derived neurotrophic factor (BDNF) gene with susceptibility to ADHD. Mol. Psychiatry 10, 939-943 (2005).
236. Sheehan K, Lowe N, Kirley A et al.: Tryptophan hydroxylase 2 (TPH2) gene variants associated with ADHD. Mol. Psychiatry 10, 944-949 (2005).
237. Quist JF, Barr CL, Schachar R et al.: The serotonin 5-HT1B receptor gene and attention deficit hyperactivity disorder. Mol. Psychiatry 8, 98-102 (2003).
238. Veenstra-VanderWeele J, Kim SJ, Lord C et al.: Transmission disequilibrium studies of the serotonin 5-HT2A receptor gene (HTR2A) in autism. Am. J. Med. Genet. 114, 277-283 (2002).
239. Jamain S, Bncur C, Quach H et al.: Linkage and association of the glutamate receptor 6 gene with autism. Mol. Psychiatry 7, 302-310 (2002).
240. Borglum AD, Kirov G, Craddock N et al.: Possible parent-of-origin effect of Dopa decarboxylase in susceptibility to bipolar affective disorder. Am. J. Med. Genet. B Neuropsychiatr Genet 117B, 18-22 (2003).
241. Muglia P, Petronis A, Mundo E, Lander S, Cate T, Kennedy JL: Dopamine D4 receptor and tyrosine hydroxylase genes in bipolar disorder: evidence for a role of DRD4. Mol. Psychiatry 7, 860-866 (2002).
242. Ni X, Trakalo JM, Mundo E, Lee L, Parikh S, Kennedy JL: Family-based association study of the serotonin-2A receptor gene (5-HT2A) and bipolar disorder. Neuromolecular Med. 2, 251-259 (2002).
243. Bickeboller H, Kistler M, Scholz M: Investigation of the candidate genes ACTHR and golf for bipolar illness by the transmission/disequilibrium test. Genet Epidemiol 14, 575-580 (1997).
244. Bah J, Quach H, Ebstein RP et al.: Maternal transmission disequilibrium of the glutamate receptor GRIK2 in schizophrenia. Neuroreport 15, 1987-1991 (2004).
245. Golimbet VE, Aksenova MG, Nosikov VV, Orlova VA, Kaleda VG: Analysis of the linkage of the Taq1A and Taq1B loci of the dopamine D2 receptor gene with schizophrenia in patients and their siblings. Neurosci. Behav. Physiol. 33, 223-225 (2003).
246. Yang J, Cai J, Zhang Y et al.: Induced pluripotent stem cells can be used to model the genomic imprinting disorder Prader- Willi syndrome. J. Biol. Chem. doi: 10.1074/ jbc.M110.183392 (2010) (Epub ahead of print).
247. Chamberlain SJ, Chen PF, Ng KY et al.: Induced pluripotent stem cell models of the genomic imprinting disorders Angelman and Prader-Willi syndromes. Proc. Natl Acad. Sci. USA 107, 17668-17673 (2010).
248. Bressler J, Tsai TF, Wu MY et al.: The SNRPN promoter is not required for genomic imprinting of the Prader-Willi/Angelman domain in mice. Nat. Genet. 28, 232-240 (2001).
249. Jiang Y, Tsai TF, Bressler J, Beaudet AL: Imprinting in Angelman and Prader-Willi syndromes. Curr. Opin. Genet. Dev. 8, 334-342 (1998).
250. Muscatelli F, Abrous DN, Massacrier A et al.: Disruption of the mouse Necdin gene results in hypothalamic and behavioral alterations reminiscent of the human Prader-Willi syndrome. Hum. Mol. Genet. 9, 3101-3110 (2000).
251. Bischof JM, Stewart CL, Wevrick R: Inactivation of the mouse Magel2 gene results in growth abnormalities similar to Prader-Willi syndrome. Hum. Mol. Genet. 16, 2713-2719 (2007).
252. Kozlov SV, Bogenpohl JW, Howell MP et al.: The imprinted gene Magel2 regulates normal circadian output. Nat. Genet. 39, 1266-1272 (2007).
253. Mercer RE, Wevrick R: Loss of magel2, a candidate gene for features of Prader-Willi syndrome, impairs reproductive function in mice. PLoS ONE 4, e4291 (2009).
254. Ding F, Li HH, Zhang S et al.: SnoRNA Snord116 (Pwcr1/MBII-85) deletion causes growth deficiency and hyperphagia in mice. PLoS ONE 3, e1709 (2008).
255. Lane PW, Davisson MT: Patchy fur (Paf), a semidominant X-linked gene associated with a high level of X-Y nondisjunction in male mice. J. Hered. 81, 43-50 (1990).
256. Lyon MF, Hawker SG: Reproductive lifespan in irradiated and unirradiated chromosomally XO mice. Genet. Res. 21, 185-194 (1973).
257. Hultcrantz M, Sylven L, Borg E: Ear and hearing problems in 44 middle-aged women with Turners syndrome. Hear. Res. 76, 127-132 (1994).
258. Deckers JFM, Kroon PHW, Douglas LT: Some characteristics of the XO mouse (Mus musculus L.) II. Reproduction: fertility and gametic segregation. Genetica 57(1), 3-11 (1981).
259. Thornhill AR, Burgoyne PS: A paternally imprinted X chromosome retards the development of the early mouse embryo. Development 118, 171-174 (1993).
260. Burgoyne PS, Baker TG: Perinatal oocyte loss in XO mice and its implications for the aetiology of gonadal dysgenesis in XO women. J. Reprod. Fertil. 75, 633-645 (1985).
261. Collins AL, Levenson JM, Vilaythong AP et al.: Mild overexpression of MeCP2 causes a progressive neurological disorder in mice. Hum. Mol. Genet. 13, 2679-2689 (2004)